Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Spine Dx firm attracts $3.5m investment

This article was originally published in Clinica

  • News

Executive Summary

Ortho Kinematics, a company developing spine motion analysis technology, said it will step up and expand its US commercialisation plans after having raised $3.5m in new capital. Investors in the Austin, Texas company were PTV Sciences, the State of Texas Emerging Technology Fund and Gatebridge Investments. Ortho Kinematics is currently rolling out its KineGraph VMA (vertebral motion analyser) which offers spine surgeons a noninvasive method of assessing the quality and quantity of inter-vertebral motion. The technology is already installed in two US hospitals and one in the UK – the company plans to install the product in several additional US hospitals over the next six months.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Discreet Gait Freezing Solution Brings Therapy With The Tap Of An Apple Watch

Shuren Says CDRH Is ‘Turning The Ship Around’ As Operations Return To Normal

EU: Good News For IVDs And For Future Transparency Of Medtech Compliance

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

See All
UsernamePublicRestriction

Register

MT044734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By